IP Library Granted Patent US 8,250,673
Granted Patent B2
US 8,250,673 · App. 13/370,640 · Granted Aug 28, 2012

Nitrile rubber article having natural rubber characteristics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,250,673
App. No.
13/370,640
Granted
Aug 28, 2012
Kind
B2
Abstract

An improved process and material for making elastomeric nitrile rubber articles is disclosed. In particular, the process and material formulation can produce nitrile rubber based articles, which exhibit force-strain characteristics that are comparable to those of natural rubber latex articles, while maintaining the tensile strength properties of nitrile rubber. The process includes an accelerator composition at the pre-cure stage having a dithiocarbamate, a thiazole, and a guanidine compound. The invention also includes an elastomeric nitrile rubber product made by the process, such as examination, surgical, or work gloves.

Claims (20)

1. An elastomeric glove comprising: a glove substrate formed from a formulation containing a carboxylated nitrile-butadiene random terpolymer composition having an acrylonitrile content of between about 17 wt. % to 45 wt. %, a carboxylic acid content of up to about 15 wt. %, and the remaining balance of the terpolymer being butadiene and having a glass transition temperature (Tg) in a range of about −15° C. to about −30° C., and in terms of parts per 100 dry parts of rubber consisting of the carboxylated nitrile-butadiene random terpolymer, between 0-1.5 parts of an alkali agent that provides monovalent ions and 0.5-1.5 parts of a metallic oxide wherein the total combined amount of the alkali agent and metallic oxide is greater than 1.0 part per 100 dry parts of rubber, the glove substrate having a thickness of from about 0.05 to about 0.12 mm in a palm region of the glove, the glove substrate requiring a force of less than or equal to about 2.5 N to cause a 400 percent elongation (F-400) from initial dimensions and the glove substrate further exhibiting a substantially linear force-to-strain response up to about 300 percent elongation (F-300) from initial dimensions when tested in accordance with ASTM D412-98a.

2. The elastomeric glove according to claim 1 , wherein the alkali agent is selected from potassium hydroxide, ammonium hydroxide, or the like and combinations thereof.

3. The elastomeric glove according to claim 1 , wherein said formulation further includes, a stabilizer and, one or more accelerator from a group including a guanidine, dithiocarbamate, and optionally a thiazole compound.

4. The elastomeric glove according to claim 3 , wherein said accelerator comprises: zinc diethyldithiocarbamate (ZDEC), zinc 2-mercaptobenzithiazole (ZMBT), and diphenyl guanidine (DPG).

5. The elastomeric glove according to claim 3 , wherein said guanidine, dithiocarbamate, and thiazole, are in a ratio of about 2:1:1, respectively.

6. The elastomeric glove according to claim 1 , wherein said force at 300% elongation (F-300) of the glove substrate is up to about 1.5 N.

7. The elastomeric glove according to claim 1 , wherein the glove substrate may be extended up to about 500% elongation with a force of less than 3 N.

8. The elastomeric glove according to claim 1 , wherein said palm region of said glove has a thickness in the range from about 0.05 mm to about 0.10 mm.

9. The elastomeric glove according to claim 1 , wherein said force at 300% elongation (F-300) of the glove substrate is about 1.8 N.

10. The elastomeric glove according to claim 1 , wherein said force at 300% elongation (F-300) of the glove substrate is about 0.9 N.

11. The elastomeric glove according to claim 1 , wherein said F-400 is less than about 2.2 N.

12. The elastomeric glove according to claim 1 , wherein said F-400 is less than about 2.0 N.

13. The elastomeric glove according to claim 1 , wherein said glove substrate exhibits a force-to-break (F-BE) of at least about 6.5 N.

14. The elastomeric glove according to claim 1 , wherein said glove substrate exhibits a force-to-break (F-BE) of up to about 15 N.

15. The elastomeric glove according to claim 1 , wherein said glove substrate exhibits a tensile strength of about 30 MPa to about 58 MPa.

16. The elastomeric glove according to claim 1 , wherein said glove substrate has an elastic modulus in a range of from about 3 MPa to about 6 MPa at about 300% stretch elongation.

17. An elastomeric glove comprising: a glove substrate formed from a formulation containing a carboxylated nitrile-butadiene random terpolymer composition having a glass transition temperature (Tg) in a range of about −15° C. to about −30° C., and in terms of parts per 100 dry parts of rubber consisting of the carboxylated nitrile-butadiene random terpolymer, between 0-1.5 parts of an alkali agent providing a monovalent ion and 0.5-1.5 parts of a metallic oxide wherein the total combined amount of the alkali agent and metallic oxide is greater than 1.0 part per 100 dry parts of rubber, the glove substrate having a thickness of from about 0.05 to about 0.12 mm in a palm region of the glove, the glove substrate requiring a force of less than or equal to about 2.5 N to cause a 400 percent elongation (F-400) from initial dimensions and the glove substrate further exhibiting a substantially linear force-to-strain response up to about 300 percent elongation (F-300) from initial dimensions at a force up to about 1.5 N when tested in accordance with ASTM D412-98.

18. The elastomeric glove according to claim 17 , wherein the alkali agent is selected from potassium hydroxide, ammonium hydroxide, or the like and combinations thereof.

19. An elastomeric glove comprising: a glove substrate formed from a formulation containing a carboxylated nitrile-butadiene random terpolymer composition having an acrylonitrile content of between about 17 wt. % to 45 wt. %, a carboxylic acid content of up to about 15 wt. %, and the remaining balance of the terpolymer being butadiene, and a glass transition temperature (Tg) in a range of about −15° C. to about −30° C., and in terms of parts per 100 dry parts of rubber consisting of the carboxylated nitrile-butadiene random terpolymer, between 0-1.5 parts of an alkali agent providing a monovalent ion and 0.5-1.5 parts of a metallic oxide wherein the total combined amount of the alkali agent and metallic oxide is greater than 1.0 part per 100 dry parts of rubber, the glove substrate having a thickness of from about 0.05 to about 0.12 mm in a palm region of the glove, the glove substrate requiring a force of less than or equal to about 2.5 N to cause a 400 percent elongation (F-400) from initial dimensions and the glove substrate further exhibiting a substantially linear force-to-strain response up to about 300 percent elongation (F-300) from initial dimensions at a force up to about 1.5 N when tested in accordance with ASTM D412-98a.

20. The elastomeric glove according to claim 19 , wherein the alkali agent is selected from potassium hydroxide, ammonium hydroxide, or the like and combinations thereof.

Assignments (15)
SECURITY INTEREST Recorded May 19, 2026
From: O&M HALYARD, INC.; MEDICAL ACTION INDUSTRIES INC.; OWENS & MINOR DISTRIBUTION, INC.
To: PLC AGENT LLC
Reel/Frame 075647/0354 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2026
From: BANK OF AMERICA, N.A.
To: MEDICAL ACTION INDUSTRIES INC.; O&M HALYARD, INC.; OWENS & MINOR DISTRIBUTION, INC.
Reel/Frame 074203/0026 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2026
From: JPMORGAN CHASE BANK, N.A.
To: O&M HALYARD, INC.; OWENS & MINOR DISTRIBUTION, INC.
Reel/Frame 074212/0570 →
SECURITY AGREEMENT (ABL) Recorded Dec 31, 2025
From: MEDICAL ACTION INDUSTRIES INC.; O&M HALYARD, INC.; OWENS & MINOR MEDICAL, LLC
To: BANK OF AMERICA, N.A., AS LEAD COLLATERAL AGENT; PNC BANK, NATIONAL ASSOCIATION, AS CO-COLLATERAL AGENT; WELLS FARGO BANK, NATIONAL ASSOCIATION, AS CO-COLLATERAL AGENT
Reel/Frame 074161/0401 →
RELEASE OF SECURITY INTEREST Recorded Jun 30, 2022
From: CITIBANK, N.A.
To: AVENT, INC.; AVANOS MEDICAL SALES, LLC
Reel/Frame 060557/0062 →
PATENT SECURITY AGREEMENT Recorded Mar 29, 2022
From: O&M HALYARD, INC.; OWENS & MINOR DISTRIBUTION, INC.
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 059541/0024 →
PATENT SECURITY AGREEMENT Recorded Mar 12, 2021
From: MEDICAL ACTION INDUSTRIES INC.; OWENS & MINOR DISTRIBUTION, INC.; O&M HALYARD, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 055582/0407 →
RELEASE OF SECURITY INTEREST Recorded Mar 12, 2021
From: BANK OF AMERICA, N.A.
To: OWENS & MINOR DISTRIBUTION, INC.; MEDICAL ACTION INDUSTRIES, INC.; O&M HALYARD, INC.
Reel/Frame 055583/0722 →
INTELLECTUAL PROPERTY SECURITY INTEREST ASSIGNMENT AGREEMENT Recorded Jan 23, 2019
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: CITIBANK, N.A.
Reel/Frame 048173/0137 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2018
From: AVENT, INC., A SUBSIDIARY OF HALYARD HEALTH, INC.
To: O&M HALYARD, INC.
Reel/Frame 047051/0692 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2018
From: LIPINSKI, TIMOTHY M.
To: KIMBERLY-CLARK WORLDWIDE, INC.
Reel/Frame 046843/0449 →
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded May 8, 2018
From: O&M HALYARD, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 046100/0646 →
RELEASE OF SECURITY INTEREST Recorded May 1, 2018
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: AVENT, INC.
Reel/Frame 046476/0710 →
SECURITY INTEREST Recorded Apr 6, 2015
From: AVENT, INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 035375/0867 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2015
From: KIMBERLY-CLARK WORLDWIDE, INC.
To: AVENT, INC.
Reel/Frame 034753/0001 →